Chevallier, Marie http://orcid.org/0000-0002-1589-0144
,
Durrmeyer, Xavier
Ego, Anne
Debillon, Thierry
Funding for this research was provided by:
Direction Générale de l’offre de Soins (PHRC-N 170176)
Article History
Received: 14 April 2020
Accepted: 29 April 2020
First Online: 8 May 2020
Ethics approval and consent to participate
: The study n°2018–002876-41 (EudraCT) was approved by the French research ethics committee on March 3, 2019 and by the French drug administration, on October 5, 2018. This one covers all study sites during the study. Considering the emergency context of most situations, anticipated written informed consent is sought from mothers, and ideally both parents, as soon as possible after the admission of the mother to the delivery room or at admission of the neonate to the NICU.
: All authors have given the consent for publication.
: The authors declare that they have no competing interests.